Asston Pharmaceuticals Ltd

Fri 18/09/2026,16:1:0 | BSE : APL

₹108.50-0.45 (-0.41%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 107.50

Previous Close

₹ 108.95

Volume

5000

Mkt Cap ( ₹ Cr)

₹ 92.36

High

₹ 108.50

Low

₹ 106.55

52 Week High

₹ 126.10

52 Week Low

₹ 60.00

Book Value Per Share

₹ 45.65

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Asston Pharmaceuticals Ltd

Your Vote -

Buy

71.43%

Hold

0.00%

Sell

28.57%

71.43%

7 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Asston Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Asston Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended April 05, 2026

    15 Sep 2026, 7:00AM As of April 2026, 50.66% is owned by Indian Promoters and 49.34% by Public. <p align=justify> Top three Promoters holding highest number of shares of

  • Asston Pharma. - Reg. 34 (1) Annual Report.

    7 Sep 2026, 6:07PM 7th Annual Report of Asston Pharmaceuticals Limited for the Financial Year 2025-26.

  • Asston Pharma. - Notice Of 7Th Annual General Meeting

    7 Sep 2026, 5:42PM Notice of 7th Annual General Meeting scheduled to be held on 29th September, 2026 at 12:30 P.M.

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Allotment

    5 Sep 2026, 1:13PM Allotment of 24,10,431 equity shares via Preferential Allotment

  • Asston Pharma. - Board Meeting Outcome for Allotment Of 24,10,431 Equity Shares Via Preferential Allotment

    5 Sep 2026, 1:09PM Allotment of 24,10,431 equity shares via Preferential Allotment

  • Asston Pharma. - Fixing Record Date

    4 Sep 2026, 7:45PM Fixing Record date/Cut-off date to determine eligible shareholders for the E-voting facility for the 7th Annual General Meeting of the Company

  • Asston Pharma. - Fixing 29Th September 2026 As The Date For Convening The 7Th Annual General Meeting Of The Company.

    4 Sep 2026, 7:40PM Fixing 29th September, 2026, as the date for convening the 7th Annual General Meeting of the Company.

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Meeting Updates

    4 Sep 2026, 7:37PM Meeting Update

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Change in Management

    4 Sep 2026, 7:35PM Change in Management

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    4 Sep 2026, 7:33PM Appointment of Statutory Auditor

  • Asston Pharma. - Board Meeting Outcome for Out Come Of The Board Meeting

    4 Sep 2026, 7:31PM Outcome of the Board Meeting.

  • Asston Pharma. - Board Meeting Intimation for Convening 7Th Annual General Meeting Of The Company

    27 Aug 2026, 8:24PM Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consid

  • Asston Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    3 Aug 2026, 7:45PM Voting Result and Scrutinizer report for EGM held on 31st July, 2026 through VC-OAVM

  • Asston Pharma. - Shareholder Meeting / Postal Ballot-Outcome of EGM

    31 Jul 2026, 1:15PM Outcome and Proceedings of the 2nd Extraordinary General Meeting for F.Y. 2026-27, scheduled to be held on 31st July, 2026, at 12:30 P.M. through Vide

  • Asston Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2026, 4:06PM Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation, 2018.

  • Asston Pharma. - Notice Of Second Extraordinary General Meeting For F.Y. 2026-27 Scheduled To Be Held On 31St July, 2026 At 1

    9 Jul 2026, 4:49PM Notice of Second Extraordinary General Meeting for F.Y. 2026-27

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Meeting Updates

    2 Jul 2026, 6:47PM Meeting Update

  • Asston Pharma. - Announcement Regarding Extraordinary General Meeting Of The Company.

    2 Jul 2026, 6:42PM Announcement regarding Extraordinary General Meeting of the Company.

  • Asston Pharma. - Update On Board Meeting Scheduled To Be Held On 02Nd July, 2026.

    2 Jul 2026, 6:36PM Update on Board Meeting Scheduled to be held on 02nd July, 2026.

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Preferential Issue

    2 Jul 2026, 6:27PM Disclosure under regulation 30 (LODR)- Preferential Issue

  • Asston Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting Scheduled To Be Held On 02Nd July, 2026.

    2 Jul 2026, 6:22PM Outcome of the Board Meeting Scheduled to be held on 02nd July, 2026.

  • Asston Pharma. - Board Meeting Intimation for Board Meeting Intimation

    24 Jun 2026, 6:41PM Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2026 ,inter alia, to consid
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Asston Pharmaceuticals Ltd stock 

Name March-26 March-25 March-24 March-23 March-21
Assets 43.9698 17.9749 13.2124 7.231 2.4021
Liabilities 43.9698 17.9749 13.2124 7.231 2.4021
Equity 8.5124 6.2714 0.7839 0.7 0.01
Gross Profit -0.5654 6.1593 2.5458 1.5165 0.1671
Net Profit 3.8652 4.3251 1.3603 1.0566 0.0916
Cash From Operating Activities -10.1795 -0.1628 -3.8003 -0.3157 -0.7305
NPM(%) 15.17 17.27 8.72 16.16 1.14
Revenue 25.4688 25.0392 15.5862 6.538 8.034
Expenses 26.0342 18.8799 13.0404 5.0215 7.8669
ROE(%) 9.94 11.12 3.5 2.71 0.23

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Asston Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 847.25 -0.18 21.08 62.18 -26.19 0.60
Lotus Eye Hospital and Institute Ltd 112.65 -1.96 1644.29 226.58 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 14.16 -2.95 0.00 470.45 -39.50 0.00
Astec Lifesciences Ltd 732.00 -3.29 0.00 242.76 -363.14 0.00

Company Info

Our Company was originally incorporated as "Asston Pharmaceuticals Private Limited", a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was converted into a public limited company and the name of our Company was changed from "Asston Pharmaceuticals Private Limited" to "Asston Pharmaceuticals Limited" vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. "Asston Pharmaceuticals Private Limited" under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple products,enhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021, less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company's achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.

Our Company was originally incorporated as "Asston Pharmaceuticals Private Limited", a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was converted into a public limited company and the name of our Company was changed from "Asston Pharmaceuticals Private Limited" to "Asston Pharmaceuticals Limited" vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. "Asston Pharmaceuticals Private Limited" under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple products,enhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021, less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company's achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.

Parent Organisation

Asston Pharmaceuticals Ltd.

Founded

16/04/2019

Managing Director

Dr.Ashish Narayan Sakalkar

NSE Symbol

FAQ